July 11, 2024
GeneDx to Report Second Quarter 2024 Financial Results on Tuesday, July 30, 2024
June 10, 2024
GeneDx Announces Collaboration with Epic Aura to Expand Access to Rapid Whole Genome Sequencing (rWGS) Services to Inform Diagnosis in Affected Pediatric and Neonatal Patients
June 5, 2024
GeneDx Announces Patient Access Program to Expand Access to Exome Testing for Pediatric Epilepsy Patients
May 22, 2024
GeneDx to Participate in Upcoming Investor Conferences
April 29, 2024
GeneDx Reports First Quarter 2024 Financial Results and Business Highlights
April 23, 2024
GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset
April 4, 2024
GeneDx to Report First Quarter 2024 Financial Results on Monday, April 29, 2024
March 14, 2024
GeneDx to Present Data at the 2024 American College of Medical Genetics (ACMG) Annual Meeting Demonstrating Clinical Superiority of its Exome, Paving the Way for the Future of Genomics
February 26, 2024
GeneDx to Participate in 44th Annual Cowen Health Care Conference
February 20, 2024
GeneDx Reports Fourth Quarter and Full Year 2023 Financial Results and Issues Guidance for Full Year 2024
Displaying 1 - 10 of 13